Robert Clancy, PhD
New York University of Medicine-New York City, NY
Endothelial Reactivity Predict Progression of Lupus Nephritis
Marcus Clark, MD
The University of Chicago-Chicago, IL
In situ Immunoglobulin Repertoire in Human Lupus Nephritis
Paulo Colombo, MD
Columbia University-New York City, NY
Biomarkers of Endothelial Activation and Vascular Inflammation in SLE
Karen Costenbader, MD, MPH
Brigham and Women's Hospital, Inc.-Boston, MA
CD44 Variants as Novel T Cell SLE Biomarkers
Andrew Hoofnagle, MD, PhD
University of Washington-Seattle, WA
Biomarkers of Atherosclerosis in Systematic Lupus Erythematosus
Marianna Kaplan, MD
The Regents of the University of Michigan-Ann Arbor, MI
Role of PPAR-gamma agonists in marine lupus
Ulla Knaus, PhD
The Scripps Research Institute-Ls Jolla, CA
Supramolecular Approach for Type I Interferon Inhibition in Lupus
Susan Kovats, PhD
Oklahoma Medical Research Foundation-Oklahoma City, OK
Regualtion of dendritic cells by estrogen receptors during lupus nephritis
Eline Luning Prak, MD, PhD
The Trustees of the University of Pennsylvania-Philadelphia, PA
Receptor Editing in SLE
Megan Mackay, MD
The Feinstein Institute for Medical Research-Manhasse, NY
Molecualr Signatures in Lupus: Untangling infection from inflammation
Erik Peterson, MD
University of Minnesota-Twin Cities-Minneapolis, MN
Prognostic utility of gene expression signatures in ANA positive subjects
Paula Pitha-Rowe, PhD
Johns Hopkins University School of Medicine-Baltimore, MD
PPAR Gamma and Adiponectin in Lupus Nephritis and Artherosclerosis
Victoria Werth, MD
The Trustees of the University of Pennsylvania-Philadelphia, PA
Biomarkers for Cutaneous Lupus Erythematosus treated with Lenalidomide
Cornelia Weyland, MD
Emory University-Atlanta, GA
Immune Mechanism of Cardiovascular Disease in SLE
|
|